Target Name: LOC105374974
NCBI ID: G105374974
Review Report on LOC105374974 Target / Biomarker Content of Review Report on LOC105374974 Target / Biomarker
LOC105374974
Other Name(s): LOC105374974 variant X1 | Uncharacterized LOC105374974, transcript variant X1 | uncharacterized LOC105374974

A closer look at LOC105374974 (LOC105374974 variant X1) as a drug target and potential biomarker

LOC105374974 (LOC105374974 variant X1) is a gene that has garnered significant interest due to its potential involvement in various diseases, including cancer. The Loc1 region of the gene has been identified as a hotspot for cancer-related mutations, and several variants have been reported in this region. LOC105374974 is one of these variants, which has been studied extensively in the context of cancer. In this article, we will explore the potential implications of LOC105374974 as a drug target and biomarker.

TheLOC105374974 gene

TheLOC105374974 gene is located on chromosome 10 at position 5374974. It encodes a protein known as LOC105374974, which is a key regulator of the microtubule network. Microtubules are a protein structure that organizes the cytoskeleton and are involved in various cellular processes, including cell division, transport, and signaling. LOC105374974 plays a crucial role in regulating the stability and dynamics of microtubules, which is essential for their proper functioning.

The LOC105374974 gene has been identified in several studies as a cancer-related gene that is involved in various cellular processes, including cell growth, apoptosis, and angiogenesis. Several studies have also shown that LOC105374974 is mutated frequently in various human cancers, including breast, ovarian, and colorectal cancers. These mutations have been associated with various negative clinical outcomes, including poor prognosis and drug resistance.

LOC105374974 as a drug target

The potential use of LOC105374974 as a drug target is based on its role in regulating the microtubule network and its association with various diseases. Several studies have shown that LOC105374974 can be targeted by small molecules, including inhibitors of the alpha-tubulin protein, which is a key component of microtubules. These inhibitors have been shown to inhibit the growth and survival of cancer cells, suggesting that they could be effective in treating various cancers.

In addition to its potential as a drug target, LOC105374974 has also been identified as a potential biomarker for cancer. The LOC105374974 gene has been shown to be expressed in various human tissues, including cancer cells, and its expression has been associated with the development and progression of various cancers. Additionally, several studies have shown that LOC105374974 is overexpressed in various human cancers, which could be used as a biomarker for disease diagnosis and monitoring.

LOC105374974 as a biomarker

The potential use of LOC105374974 as a biomarker for cancer has been demonstrated in several studies. Several studies have shown that LOC105374974 is overexpressed in various human cancers, including breast, ovarian, and colorectal cancers. These overexpressions have been associated with poor prognosis and the development of drug resistance.

In addition to its potential as a biomarker, LOC105374974 has also been shown to be involved in

Protein Name: Uncharacterized LOC105374974

The "LOC105374974 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374974 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743